cysteine has been researched along with s-trans,trans-farnesylthiosalicylic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aviram, I; Halpern, M; Kloog, Y; Marciano, D; Tisch, D | 1 |
| Aharonson, Z; Gana-Weisz, M; Haklai, R; Kloog, Y; Marciano, D; Varsano, T | 1 |
| Haklai, R; Kloog, Y; Makovski, V | 1 |
3 other study(ies) available for cysteine and s-trans,trans-farnesylthiosalicylic acid
| Article | Year |
|---|---|
Activation of signaling pathways in HL60 cells and human neutrophils by farnesylthiosalicylate.
Topics: Calcium; Cell Compartmentation; Cysteine; Enzyme Activation; Enzyme Inhibitors; Farnesol; GTP-Binding Proteins; HL-60 Cells; Humans; Inositol 1,4,5-Trisphosphate; NADPH Oxidases; Neutrophils; Pertussis Toxin; Phospholipases; Protein Kinase C; Respiratory Burst; Salicylates; Signal Transduction; Staurosporine; Superoxides; Virulence Factors, Bordetella | 1996 |
Stringent structural requirements for anti-Ras activity of S-prenyl analogues.
Topics: Animals; Cell Division; Cell Line; Cysteine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesol; ras Proteins; Rats; Salicylates; Transfection | 1998 |
Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cysteine; Farnesol; Lymphangioleiomyomatosis; Lymphocytes, Null; Mice; Mice, Nude; Monomeric GTP-Binding Proteins; Mutation; Neuropeptides; Phosphorylation; Ras Homolog Enriched in Brain Protein; ras Proteins; Rats; Ribosomal Protein S6 Kinases; Salicylates; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2012 |